Shemesh Shay

Average Profitability
27.08%
Insider Buys Quantity
13
Insider Buys Sum
$69,688.72
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Shemesh Shay

According to the SEC Form 4 filings, Shemesh Shay, being in a position of

  1. Chief Dev. & Ops. Officer at Nuvectis Pharma, Inc.,
    оver the last 12 months, has bought 1113 shares for $7,034, and sold 0 shares,
    over all time since 2022-02-04, has bought 11329 shares for $69,689, and sold 0 shares.

The largest purchase of all time was on 2022-02-04 and amounted to 4200 shares of Nuvectis Pharma, Inc. for $14,196.

Biography of Shemesh Shay

No biography is available at this moment.

2024-05-10PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
1,113
0.006%
$6.32$7,034+2.03%
2023-03-21PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
420
0.0028%
$11.99$5,036+0.57%
2023-03-15PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
670
0.0044%
$10.71$7,176+13.59%
2022-12-21PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
500
0.0041%
$7.65$3,825+73.27%
2022-11-17PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
150
0.0012%
$7.20$1,080+76.88%
2022-11-16PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
150
0.0012%
$7.10$1,065+79.37%
2022-09-02PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
404
0.0029%
$8.31$3,357+36.79%
2022-08-31PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
1,530
0.0108%
$8.07$12,347+38.09%
2022-05-20PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
300
0.0025%
$16.54$4,962-41.35%
2022-05-16PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
142
0.0011%
$19.55$2,776-51.74%
2022-05-12PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
58
0.0004%
$16.61$963-48.66%
2022-02-07PurchaseNuvectis Pharma, Inc.
NVCT
Chief Development Officer
1,692
0.0081%
$3.47$5,871+1.38%
2022-02-04PurchaseNuvectis Pharma, Inc.
NVCT
Chief Development Officer
4,200
0.0477%
$3.38$14,196+146.77%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.